Washington University School of Medicine; Asterias Biotherapeutics Opens Additional Clinical Site for AST-OPC1 SCiStar Study


FREMONT, Calif., Aug. 23, 2017 (STL.NEWS) — Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company pioneering the field of regenerative medicine, today announced that Washington University School of Medicine in St. Louis, MO, has bee…
http://bit.ly/2wF0ELk

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s